Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed (MMM) industrial conglomerate with $23.1B revenue and 60K+ products (Scotch, Post-it, Nexcare); 2024 healthcare spinoff as Solventum after resolving $16B+ in PFAS and earplug litigation.
3M is a Saint Paul, Minnesota-based global manufacturing conglomerate producing over 60,000 products across four business segments — Safety & Industrial (protective equipment, adhesive tapes, abrasives), Transportation & Electronics (automotive films, electronics materials, optical products), Health Care (medical supplies, dental products, health information systems), and Consumer (Scotch tape, Post-it notes, Nexcare healthcare products). Listed on NYSE (NYSE: MMM), 3M generated $23.1 billion in revenue in fiscal year 2024 and employs approximately 87,000 people globally, making it one of the most diversified industrial companies in the US.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.